Ambulatory Care

门诊护理
  • 文章类型: Journal Article
    BACKGROUND: The fast-growing migrant population in Japan and globally poses challenges in mental healthcare, yet research addressing migrants\' mental health treatment engagement remains limited.
    OBJECTIVE: This study examined language proficiency, demographic and clinical characteristics as predictors of early treatment discontinuation among migrants.
    METHODS: Electronic health record data from 196 adult migrants, identified from 14 511 patients who received mental health outpatient treatment during 2016 and 2019 at three central hospitals in the Tokyo-Yokohama metropolitan region of Japan, were used. We conducted multivariable regression models to identify predictors of early discontinuation within 3 months.
    RESULTS: The study cohort (65% women, age range: 18-90 years, from 29 countries or regions) included 23% non-Japanese speakers. Japanese and non-Japanese speakers had similar discontinuation rates (26% vs 22%). Multivariable models revealed younger age (OR=0.97; 95% CI: 0.95, 0.99; p=0.016) and those with a primary diagnosis other than a schizophrenia spectrum disorder (OR=3.99; 95% CI: 1.36, 11.77; p=0.012) or a neurotic, stress-related and somatoform disorder (OR=2.79; 95% CI: 1.14, 6.84; p=0.025) had higher odds of early discontinuation. These effects were more pronounced among the Japanese speakers with significant language-by-age and language-by-diagnoses interactions.
    CONCLUSIONS: Younger age and having a primary diagnosis other than a schizophrenia spectrum disorder or a neurotic, stress-related and somatoform disorder increased vulnerability for discontinuing mental health treatment early in Japanese-speaking migrants but not for migrants with limited Japanese proficiency.
    CONCLUSIONS: Understanding language needs within a context of mental health treatment should go beyond assumed or observed fluency. Unmet language needs might increase vulnerability for treatment disengagement among migrants. Targeted clinical efforts are crucial for enhancing early treatment engagement and informing health practices in Japan and countries with growing migrant populations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    巴西的公共医疗系统(SUS)为巴西人提供专门的口腔健康服务,但是专家的生产力,比如儿科牙医,没有被定性。因此,本研究的目的是描述SUS中儿科牙医进行的门诊牙科手术(ODP)的特征.一项生态学的流行病学研究,纵向,回顾性,并进行了定量研究。由SUS内的儿科牙医进行的ODP根据程序类型进行表征,复杂性级别,和情况(紧急或选修)。使用描述性和分析方法对数据进行分析,考虑到5%的显著性水平,以及COVID-19大流行的影响(2020-2022年未包括在二次分析中)。在过去的15年里,29,234,972ODP由SUS内的儿科牙医进行。临床程序占多数(55.4%),明显比所有其他类型的程序更频繁(所有p<0.05)。其中,修复和牙周手术是最常见的(30.7%和21.0%,分别)。从2008年到2019年,不包括COVID-19大流行年份,过去15年的趋势对于所有类型的手术都是恒定的(所有p>0.05).此外,低复杂度ODP占多数(90.1%),明显高于中等频率(9.7%)和高复杂性程序(0.1%)(均p<0.05)。最后,大多数ODP在门诊生产报告中没有以情况为特征(96.9%).因此,可以得出结论,在过去的15年里,儿科牙医在SUS内进行了不同的ODP,尽管存在类型和复杂性的主导模式。
    Brazil\'s public healthcare system (SUS) offers specialized oral health services to Brazilians, but the productivity of specialists, such as Pediatric Dentists, has not been characterized. Therefore, the objective of this study was to characterize the outpatient dental procedures (ODPs) carried out by Pediatric Dentists within the SUS. An epidemiological study with an ecological, longitudinal, retrospective, and quantitative approach was conducted. The ODPs carried out by Pediatric Dentists within the SUS were characterized based on type of procedure, complexity level, and circumstance (urgent or elective). Data were analyzed using a descriptive and analytical approach, considering a significance level of 5%, as well as the impact of the COVID-19 pandemic (the 2020-2022 years were not included in secondary analyses). In the last 15 years, 29,234,972 ODPs were carried out by Pediatric Dentists within the SUS. Clinical procedures were the majority (55.4%), significantly more frequent than all other types of procedures (all p <0.05). Among these, restorative and periodontal procedures were the most common (30.7% and 21.0%, respectively). From 2008 to 2019, excluding COVID-19 pandemic years, the trend over the last 15 years was constant for all types of procedures (all p >0.05). In addition, low complexity ODPs were the majority (90.1%), significantly more frequent than medium (9.7%) and high complexity procedures (0.1%) (both p <0.05). At last, most ODPs were not characterized by circumstance in the outpatient production reports (96.9%). Therefore, it was possible to conclude that Pediatric Dentists carried out diverse ODPs within the SUS over the past 15 years, although there was a dominant pattern of type and complexity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    先前工作的作者将儿童机会指数(COI)与门诊护理敏感状况(ACSC)的住院率增加相关联。这种不平等对医疗保健系统的负担是未知的。我们试图从过度住院的角度来了解医疗保健资源支出,医院的日子,和成本。
    我们对儿科健康信息系统数据库进行了回顾性横断面研究,包括2016年1月1日至2022年12月31日期间18岁以下儿童的住院情况.我们比较了ACSC的住院情况,死亡率,和COI地层的成本。
    我们确定了1969934名儿童中的2870121人住院,其中44.5%(1277568/2870121)为ACSCs。在极低阶层中,总共49.1%(331083/674548)的住院治疗是可以预防的,在极高地层中,这一比例为39.7%(222037/559003)(P<.001)。调整后,较低的COI与较高的潜在可预防的住院几率相关(比值比1.18,95%置信区间[CI]1.17-1.19).与非常高的COI地层相比,所有其他阶层共有137550例(95%CI134582-140517)超额住院,导致13亿美元的超额成本(95%CI12.8-13.5亿美元)。与非常高的COI地层相比,有813例(95%CI758-871)超额死亡,>95%来自非常低和低COI地层。
    邻里机会较低的儿童患ACSC住院的风险增加。COI可以确定有针对性的干预措施可以降低医疗保健利用率和成本的社区。
    OBJECTIVE: The authors of previous work have associated the Childhood Opportunity Index (COI) with increased hospitalizations for ambulatory care sensitive conditions (ACSC). The burden of this inequity on the health care system is unknown. We sought to understand health care resource expenditure in terms of excess hospitalizations, hospital days, and cost.
    METHODS: We performed a retrospective cross-sectional study of the Pediatric Health Information Systems database, including inpatient hospitalizations between January 1, 2016 and December 31, 2022 for children <18 years of age. We compared ACSC hospitalizations, mortality, and cost across COI strata.
    RESULTS: We identified 2 870 121 hospitalizations among 1 969 934 children, of which 44.5% (1 277 568/2 870 121) were for ACSCs. A total of 49.1% (331 083/674 548) of hospitalizations in the very low stratum were potentially preventable, compared with 39.7% (222 037/559 003) in the very high stratum (P < .001). After adjustment, lower COI was associated with higher odds of potentially preventable hospitalization (odds ratio 1.18, 95% confidence interval [CI] 1.17-1.19). Compared with the very high COI stratum, there were a total of 137 550 (95% CI 134 582-140 517) excess hospitalizations across all other strata, resulting in an excess cost of $1.3 billion (95% CI $1.28-1.35 billion). Compared with the very high COI stratum, there were 813 (95% CI 758-871) excess deaths, with >95% from the very low and low COI strata.
    CONCLUSIONS: Children with lower neighborhood opportunity have increased risk of ACSC hospitalizations. The COI may identify communities in which targeted intervention could reduce health care utilization and costs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在COVID-19大流行期间,门诊治疗中的急性呼吸道感染(ARI)抗生素处方明显减少。目前尚不清楚抗生素处方率是否会继续降低。
    方法:我们对第一波COVID-19期间和之后的抗生素处方进行了趋势分析,以确定与COVID-19之前的水平相比,门诊护理中的ARI抗生素处方率是否仍然受到抑制。回顾性数据来自ARI或UTI诊断代码的患者,他们来自纽约四个学术卫生系统内的298个初级保健和66个紧急护理实践,威斯康星州,2017年1月至2022年6月之间的犹他州。主要措施包括每100例非COVIDARI遭遇抗生素处方,遭遇卷,规定趋势,和预期趋势的变化。
    结果:在基线时,在第一波期间和之后,总体ARI抗生素处方率分别为每100次处方54.7、38.5和54.7次,分别。ARI抗生素处方率在COVID-19发病后出现统计学显著下降(阶跃变化-15.2,95%CI:-19.6至-4.8)。在第一波中,相遇量减少了29.4%,第一波之后,下降了188%。第一波之后,与基线相比,ARI抗生素处方率不再受到显着抑制(阶跃变化0.01,95%CI:-6.3至6.2)。基线与观察期结束时的UTI抗生素处方率之间没有显着差异。
    结论:COVID-19发病后观察到的ARI抗生素处方下降是暂时的,没有反映在UTI抗生素处方中,并不代表临床医生处方行为的长期变化。在人们对ARI病毒病因的认识提高的时期,观察到临床医生抗生素处方大幅减少,且有临床意义.抗生素管理的未来努力可能受益于对导致处方率降低和反弹的因素的持续研究。
    BACKGROUND: During the COVID-19 pandemic, acute respiratory infection (ARI) antibiotic prescribing in ambulatory care markedly decreased. It is unclear if antibiotic prescription rates will remain lowered.
    METHODS: We used trend analyses of antibiotics prescribed during and after the first wave of COVID-19 to determine whether ARI antibiotic prescribing rates in ambulatory care have remained suppressed compared to pre-COVID-19 levels. Retrospective data was used from patients with ARI or UTI diagnosis code(s) for their encounter from 298 primary care and 66 urgent care practices within four academic health systems in New York, Wisconsin, and Utah between January 2017 and June 2022. The primary measures included antibiotic prescriptions per 100 non-COVID ARI encounters, encounter volume, prescribing trends, and change from expected trend.
    RESULTS: At baseline, during and after the first wave, the overall ARI antibiotic prescribing rates were 54.7, 38.5, and 54.7 prescriptions per 100 encounters, respectively. ARI antibiotic prescription rates saw a statistically significant decline after COVID-19 onset (step change -15.2, 95% CI: -19.6 to -4.8). During the first wave, encounter volume decreased 29.4% and, after the first wave, remained decreased by 188%. After the first wave, ARI antibiotic prescription rates were no longer significantly suppressed from baseline (step change 0.01, 95% CI: -6.3 to 6.2). There was no significant difference between UTI antibiotic prescription rates at baseline versus the end of the observation period.
    CONCLUSIONS: The decline in ARI antibiotic prescribing observed after the onset of COVID-19 was temporary, not mirrored in UTI antibiotic prescribing, and does not represent a long-term change in clinician prescribing behaviors. During a period of heightened awareness of a viral cause of ARI, a substantial and clinically meaningful decrease in clinician antibiotic prescribing was observed. Future efforts in antibiotic stewardship may benefit from continued study of factors leading to this reduction and rebound in prescribing rates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    嵌合抗原受体(CAR)T细胞疗法(CART疗法)是复发性或难治性多发性骨髓瘤患者的治疗选择,已导致前所未有的治疗结果。在可用的CART疗法中,ciltacabtageneautoleucel(cilta-cel)由于其通常可预测的安全性而成为门诊用药的良好候选者。cilta-cel的门诊管理有多种优势,包括减轻医疗负担,扩展访问,患者自主性这项混合方法的定性研究旨在通过将有针对性的文献综述与专家访谈和小组相结合,确定CART门诊管理的关键因素和最佳实践建议。
    目标审查(第1阶段)旨在确定美国门诊CART管理的因素,并确定探索性访谈(第2阶段)和专家小组(第3阶段)的关键主题。旨在告知门诊CART管理的最佳实践和挑战(重点是cilta-cel)。招募了在治疗中心担任临床和行政职务的参与者,这些参与者具有实际门诊cilta-cel的经验。
    在第一阶段确定了17项研究。门诊管理的关键因素包括制定CART并发症的方案,对护理人员的教育,门诊专家,医院工作人员,和紧急服务人员在可能的不良事件发生后进行识别和转诊,建立多学科团队进行有效的沟通和管理,包括财务资格审查和提供患者教育材料的直接患者摄入过程,并在整个治疗过程中密切患者监测。在第二阶段,来自2个中心的5名参与者接受了采访。在第3阶段,采访了6个治疗中心的14名参与者。进行了两次90分钟的虚拟小组讨论。所有参与者都同意cilta-cel可以在门诊环境中安全有效地管理。主要建议包括为患者和护理人员创建教育资源,制定标准操作程序,专门的门诊基础设施和跨学科团队的建立,门诊毒性管理监测,以及对报销情况的监测。
    本研究全面了解参与CART中心的门诊cilta-cel管理的可行性,并在承认现有挑战的同时提供可操作的建议。
    UNASSIGNED: Chimeric antigen receptor (CAR) T-cell therapy (CAR T therapy) is a treatment option for patients with relapsed or refractory multiple myeloma that has led to unprecedented treatment outcomes. Among CAR T therapies available, ciltacabtagene autoleucel (cilta-cel) is a good candidate for outpatient administration due to its generally predictable safety profile. There are multiple advantages of outpatient administration of cilta-cel, including reduced healthcare burden, expanded access, and patient autonomy. This mixed methods qualitative study aimed to identify key factors for outpatient administration of CAR T and best practice recommendations by combining a targeted literature review with expert interviews and panels.
    UNASSIGNED: The targeted review (Phase 1) aimed to identify factors for outpatient CAR T administration in the US and determine key topics for the exploratory interviews (Phase 2) and expert panels (Phase 3), which aimed to inform on best practices and challenges of outpatient CAR T administration (focusing on cilta-cel). Participants in clinical and administrative positions based in treatment centers that had experience with real-world outpatient administration of cilta-cel were recruited.
    UNASSIGNED: Seventeen studies were identified in Phase 1. Key factors for outpatient administration included the development of protocols for CAR T complications, education for caregivers, outpatient specialists, hospital staff, and emergency services staff for identification and referral after possible adverse events, the creation of multidisciplinary teams for effective communication and management, straightforward patient intake processes encompassing financial eligibility review and provision of patient education materials, and close patient monitoring throughout the treatment journey. In Phase 2, 5 participants from 2 centers were interviewed. In Phase 3, 14 participants across 6 treatment centers were interviewed. Two 90-minute virtual panel discussions took place. All participants agreed that cilta-cel can be safely and effectively administered in an outpatient setting. Key recommendations included the creation of educational resources for patients and caregivers, the development of standard operating procedures, dedicated outpatient infrastructure and establishment of interdisciplinary teams, outpatient monitoring for toxicity management, and monitoring of the reimbursement landscape.
    UNASSIGNED: This study offers a comprehensive understanding of the feasibility of outpatient cilta-cel administration in participating CAR T centers and provides actionable recommendations while acknowledging existing challenges.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    OBJECTIVE: Was to improve the quality of treatment in pediatric outpatient dentistry with the effective use of oral sedation.
    METHODS: The study comprised 60 children aged 3-12 years who were undergoing therapeutic/surgical dental treatment. All children\'s somatic state was assessed as ASAI-II. All children met a number of psychological, anamnestic and procedural criteria. Midazolam and chloropyramine in a dose calculated for the patient\'s body weight were used as components of oral sedation. The estimated sedation depth was Ramsay II-III. The study included an analysis of objective (the time of comfortable treatment, the amount of treated or removed teeth per visit, the possibility of treatment without anesthesia during further visits) and subjective (the possibility of contact with the child during treatment, behavioral reactions at home and on further visits) criteria. Negative behavioral reactions and dental effects were also assessed.
    RESULTS: The treatment features correlated with the age category and gender of the patient. In the older age group of 7-12 years, the amount of comfortable treatment time was higher, the possibility of contact with the child reached 100% (which is twice as much as in the younger one), and also a larger number of patients were treated during further visits without an anesthetic aid. At the same time, in the younger age group of 3-6 years, the volume of treatment per visit was higher, since it takes less time to treat a primary tooth than for a permanent one. Side effects (visual hallucinations, diplopia, hyperactivity, tearfulness and aggressiveness) were more often recorded in the younger age group, but emotional instability was equally manifested in both groups.
    CONCLUSIONS: In order to maximize the effectiveness of using oral sedation as a method, it is necessary to take into account the duration and traumatism of the proposed procedure, the peculiarities of age psychology and the peculiarities of the psychological development of boys and girls.
    UNASSIGNED: Улучшить качество лечения детей в амбулаторной стоматологии путем эффективного применения пероральной седации.
    UNASSIGNED: В исследование вошли 60 детей в возрасте 3—12 лет, которым предстояло терапевтическое/хирургическое стоматологическое вмешательство. Все дети соответствовали по соматическому состоянию ASA I—II и отвечали ряду психологических, анамнестических и процедуральных критериев. В качестве компонентов пероральной седации использовались препараты мидазолам и хлоропирамин в дозе, рассчитанной на массу тела пациента. Предполагаемая глубина седации — Ramsay II—III. Анализировались объективные критерии: время комфортного лечения, объем лечения за один визит, возможность лечения без анестезиологического пособия при дальнейших визитах; а также субъективные: возможность контакта с ребенком в процессе лечения, поведенческие реакции в домашних условиях и на дальнейших визитах. Также оценивались негативные поведенческие реакции и стоматологические эффекты.
    UNASSIGNED: Особенности лечения коррелировали с возрастной категорией и полом пациента. В старшей возрастной категории 7—12 лет была больше величина комфортного времени лечения, возможность контакта с ребенком достигла 100% (что в два раза больше, чем в младшей), а также большее количество пациентов было пролечено при дальнейших визитах без анестезиологического пособия. При этом в младшей возрастной категории 3—6 лет был больше объем лечения за один визит, так как для лечения одного временного зуба необходимо меньше времени, чем для постоянного. Побочные эффекты (зрительные галлюцинации, диплопия, гиперактивность, плаксивость и агрессивность) чаще регистрировались в младшей возрастной категории, однако эмоциональная нестабильность была равно проявлена в обеих группах.
    UNASSIGNED: Для наибольшей эффективности использования пероральной седации необходимо учитывать длительность и травматичность предполагаемой процедуры, особенности возрастной психологии и особенности психологического развития мальчиков и девочек.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号